Using cancer survivorship experiences to inform cancer advocacy in Nigeria.

IF 1.3 Q4 ONCOLOGY
ecancermedicalscience Pub Date : 2025-04-10 eCollection Date: 2025-01-01 DOI:10.3332/ecancer.2025.1887
Chinelo C Nduka, Chizobam A Nweke, Runcie C W Chidebe, Candidus Nwakasi
{"title":"Using cancer survivorship experiences to inform cancer advocacy in Nigeria.","authors":"Chinelo C Nduka, Chizobam A Nweke, Runcie C W Chidebe, Candidus Nwakasi","doi":"10.3332/ecancer.2025.1887","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Nigeria has a significant cancer burden, especially breast cancer (BC), which has the highest incidence and mortality in the country. However, like many countries in sub-Saharan Africa, the focus continues to be on infectious diseases to the detriment of addressing non-communicable diseases like cancer with a resultant paucity in available funding, health infrastructure and even health workforce geared towards cancer care. All these invariably lead to very low access to cancer care, with poor patient outcomes being recorded. The purpose of this study is to explore the experiences of BC survivors who are part of a non-profit cancer advocacy group to highlight important areas of cancer survivorship that can be targeted by cancer advocacy programs and interventions in Nigeria.</p><p><strong>Method: </strong>We used a qualitative descriptive approach and recruited 19 BC survivors through a purposive sampling method. The participants were engaged in four focus group discussions. Analysis of the data resulted in four main themes with direction implications for cancer advocacy among BC survivors in Nigeria. They include 'Strengthening care interaction quality'; 'Addressing delayed presentation'; 'Expanding access to informal support' and 'Alleviating the cost burden of cancer care.' Various recommendations were made, such as better management of the Nigerian Cancer Health Fund, comprehensive cancer coverage by the National Health Insurance Authority and the need for Nigeria's National Institute for Cancer Research and Treatment to consider retention and training policies for the oncology workforce in Nigeria. This paper highlights the importance of cancer advocacy, arguing that a better understanding of cancer survivorship can strengthen cancer advocacy in Nigeria. In turn, strong cancer advocacy will help to prioritise cancer issues and mitigate a looming cancer crisis in Nigeria.</p>","PeriodicalId":11460,"journal":{"name":"ecancermedicalscience","volume":"19 ","pages":"1887"},"PeriodicalIF":1.3000,"publicationDate":"2025-04-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12149231/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ecancermedicalscience","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3332/ecancer.2025.1887","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Nigeria has a significant cancer burden, especially breast cancer (BC), which has the highest incidence and mortality in the country. However, like many countries in sub-Saharan Africa, the focus continues to be on infectious diseases to the detriment of addressing non-communicable diseases like cancer with a resultant paucity in available funding, health infrastructure and even health workforce geared towards cancer care. All these invariably lead to very low access to cancer care, with poor patient outcomes being recorded. The purpose of this study is to explore the experiences of BC survivors who are part of a non-profit cancer advocacy group to highlight important areas of cancer survivorship that can be targeted by cancer advocacy programs and interventions in Nigeria.

Method: We used a qualitative descriptive approach and recruited 19 BC survivors through a purposive sampling method. The participants were engaged in four focus group discussions. Analysis of the data resulted in four main themes with direction implications for cancer advocacy among BC survivors in Nigeria. They include 'Strengthening care interaction quality'; 'Addressing delayed presentation'; 'Expanding access to informal support' and 'Alleviating the cost burden of cancer care.' Various recommendations were made, such as better management of the Nigerian Cancer Health Fund, comprehensive cancer coverage by the National Health Insurance Authority and the need for Nigeria's National Institute for Cancer Research and Treatment to consider retention and training policies for the oncology workforce in Nigeria. This paper highlights the importance of cancer advocacy, arguing that a better understanding of cancer survivorship can strengthen cancer advocacy in Nigeria. In turn, strong cancer advocacy will help to prioritise cancer issues and mitigate a looming cancer crisis in Nigeria.

利用癌症幸存者的经历为尼日利亚的癌症倡导提供信息。
背景:尼日利亚有严重的癌症负担,特别是乳腺癌(BC),它在该国的发病率和死亡率最高。然而,与撒哈拉以南非洲的许多国家一样,重点仍然放在传染病上,不利于解决癌症等非传染性疾病,因此缺乏可用资金、卫生基础设施,甚至缺乏面向癌症护理的卫生人力。所有这些都不可避免地导致癌症治疗的可及性非常低,患者的预后记录也很差。本研究的目的是探索BC幸存者的经历,他们是一个非营利性癌症倡导组织的一部分,以突出癌症幸存者的重要领域,这些领域可以被尼日利亚的癌症倡导项目和干预措施所针对。方法:我们采用定性描述方法,通过有目的的抽样方法招募19名BC幸存者。与会者进行了四次焦点小组讨论。对数据的分析产生了四个主要主题,对尼日利亚BC幸存者的癌症宣传具有指导意义。它们包括“加强护理互动质量”;“解决延迟陈述”;“扩大获得非正式支持的机会”和“减轻癌症治疗的成本负担”。会议提出了各种建议,例如更好地管理尼日利亚癌症健康基金,国家健康保险局全面覆盖癌症,尼日利亚国家癌症研究和治疗研究所需要考虑尼日利亚肿瘤学工作人员的保留和培训政策。本文强调了癌症宣传的重要性,认为更好地了解癌症幸存者可以加强尼日利亚的癌症宣传。反过来,强有力的癌症宣传将有助于优先考虑癌症问题,并缓解尼日利亚迫在眉睫的癌症危机。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
3.80
自引率
5.60%
发文量
138
审稿时长
27 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信